|
TMEM55B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.40499953285678E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.68569977158029E-10 |
| Normal-vs-Stage2 |
3.02039999999781E-06 |
| Normal-vs-Stage3 |
3.43359999999127E-06 |
| Normal-vs-Stage4 |
4.15479999960056E-07 |
| Stage1-vs-Stage2 |
5.029200E-01 |
| Stage1-vs-Stage3 |
3.446600E-01 |
| Stage1-vs-Stage4 |
8.496600E-01 |
| Stage2-vs-Stage3 |
2.541000E-01 |
| Stage2-vs-Stage4 |
6.975200E-01 |
| Stage3-vs-Stage4 |
3.707800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.19140000274388E-09 |
| Normal-vs-AfricanAmerican |
1.52140999999384E-05 |
| Normal-vs-Asian |
4.10720000000309E-05 |
| Caucasian-vs-AfricanAmerican |
7.644800E-01 |
| Caucasian-vs-Asian |
9.759800E-01 |
| AfricanAmerican-vs-Asian |
8.455200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.31050000243371E-08 |
| Normal-vs-Female |
8.51809955904059E-10 |
| Male-vs-Female |
6.485000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.38930000836979E-09 |
| Normal-vs-Age(41-60Yrs) |
4.27000000025046E-07 |
| Normal-vs-Age(61-80Yrs) |
6.24689999728645E-09 |
| Normal-vs-Age(81-100Yrs) |
2.451900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.351000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.291800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.911400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.038200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.161000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.882800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.037400E-01 |
| Classical-VS-Follicular |
5.793600E-04 |
| Classical-VS-Other |
4.736000E-01 |
| Classical-VS-Normal |
1.86960000003733E-06 |
| Tall-VS-Follicular |
2.519600E-03 |
| Tall-VS-Other |
3.458200E-01 |
| Tall-VS-Normal |
4.980000E-03 |
| Follicular-VS-Other |
5.592000E-01 |
| Follicular-VS-Normal |
2.78839995537794E-09 |
| Other-VS-Normal |
1.817740E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.90850027290435E-10 |
| Normal-vs-N1 |
9.77260000034619E-07 |
| N0-vs-N1 |
7.072000E-01 |
|
|
